Response of intracranial metastases to erlotinib therapy

被引：45

作者：

Fekrazad, M. Houman ^{[1
]}

Ravindranathan, Meera ^{[1
]}

Jones, Dennie V., Jr. ^{[1
]}

机构：

[1] Univ New Mexico, Canc Res & Treatment Ctr, Sect Thorac Oncol, Albuquerque, NM 87131 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 31期

关键词：

D O I：

10.1200/JCO.2007.13.3751

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：5024 / 5026

页数：3

共 5 条

[1] Gefitinib in patients with brain metastases from non-small-cell lung cancer:: a prospective trial [J].

Ceresoli, GL ;

Cappuzzo, F ;

Gregorc, V ;

Bartolini, S ;

Crinó, L ;

Villa, E .

ANNALS OF ONCOLOGY, 2004, 15 (07) :1042-1047

[2] Effect of gefitinib ('Iressa', ZD1839) on brain metastases in patients with advanced non-small-cell lung cancer [J].

Hotta, K ;

Kiura, K ;

Ueoka, H ;

Tabata, M ;

Fujiwara, K ;

Kozuki, T ;

Okada, T ;

Hisamoto, A ;

Tanimoto, M .

LUNG CANCER, 2004, 46 (02) :255-261

[3] Complete response to erlotinib treatment in brain metastases from recurrent NSCLC [J].

Lai, CSL ;

Boshoff, C ;

Falzon, M ;

Lee, SM .

THORAX, 2006, 61 (01) :91-91

[4] Recurrent responses to non-small cell lung cancer brain metastases with erlotinib [J].

Popat, Sanjay ;

Hughes, Sarah ;

Papadopoulos, Panos ;

Wilkins, Anna ;

Moore, Sally ;

Priest, Kathy ;

Meehan, Linda ;

Norton, Alison ;

O'Brien, Mary .

LUNG CANCER, 2007, 56 (01) :135-137

[5] Chemotherapy for brain metastases of lung cancer: A review [J].

Postmus, PE ;

Smit, EF .

ANNALS OF ONCOLOGY, 1999, 10 (07) :753-759

← 1 →